Harnessing the Gut Microbiota to Potentiate the Efficacy of CAR T Cell Therapy

被引：3

作者：

Gabrielli, Giulia ^{[1
,2
,3
,4
]}

Shouval, Roni ^{[5
,6
]}

Ghilardi, Guido ^{[1
,2
,4
]}

van den Brink, Marcel ^{[5
,6
]}

Ruella, Marco ^{[1
,2
,4
]}

机构：

[1] Univ Penn, Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA

[2] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA

[3] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Turin, Italy

[4] Univ Penn, Sch Med, Dept Med, Div Hematol & Oncol, Philadelphia, PA 19104 USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

[6] Weill Cornell Med Coll, Dept Med, New York, NY USA

来源：

HEMASPHERE | 2023年 / 7卷 / 09期

关键词：

LISOCABTAGENE MARALEUCEL; INTESTINAL MICROBIOTA; IMMUNOTHERAPY; RECEPTOR; PROBIOTICS;

D O I：

10.1097/HS9.0000000000000950

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：7

共 80 条

[1] Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study [J].

Abramson, Jeremy S. ;

Solomon, Scott R. ;

Arnason, Jon ;

Johnston, Patrick B. ;

Glass, Bertram ;

Bachanova, Veronika ;

Ibrahimi, Sami ;

Mielke, Stephan ;

Mutsaers, Pim ;

Hernandez-Ilizaliturri, Francisco ;

Izutsu, Koji ;

Morschhauser, Franck ;

Lunning, Matthew ;

Crotta, Alessandro ;

Montheard, Sandrine ;

Previtali, Alessandro ;

Ogasawara, Ken ;

Kamdar, Manali .

BLOOD, 2023, 141 (14) :1675-1684

[2] Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study [J].

Abramson, Jeremy S. ;

Palomba, M. Lia ;

Gordon, Leo I. ;

Lunning, Matthew A. ;

Wang, Michael ;

Arnason, Jon ;

Mehta, Amitkumar ;

Purev, Enkhtsetseg ;

Maloney, David G. ;

Andreadis, Charalambos ;

Sehgal, Alison ;

Solomon, Scott R. ;

Ghosh, Nilanjan ;

Albertson, Tina M. ;

Garcia, Jacob ;

Kostic, Ana ;

Mallaney, Mary ;

Ogasawara, Ken ;

Newhall, Kathryn ;

Kim, Yeonhee ;

Li, Daniel ;

Siddiqi, Tanya .

LANCET, 2020, 396 (10254) :839-852

[3] Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics [J].

Araujo, Daniel, V ;

Watson, Geoffrey A. ;

Oliva, Marc ;

Heirali, Alya ;

Coburn, Bryan ;

Spreafico, Anna ;

Siu, Lillian L. .

CANCER TREATMENT REVIEWS, 2021, 92

[4] Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients [J].

Baruch, Erez N. ;

Youngster, Ilan ;

Ben-Betzalel, Guy ;

Ortenberg, Rona ;

Lahat, Adi ;

Katz, Lior ;

Adler, Katerina ;

Dick-Necula, Daniela ;

Raskin, Stephen ;

Bloch, Naamah ;

Rotin, Daniil ;

Anafi, Liat ;

Avivi, Camila ;

Melnichenko, Jenny ;

Steinberg-Silman, Yael ;

Mamtani, Ronac ;

Harati, Hagit ;

Asher, Nethanel ;

Shapira-Frommer, Ronnie ;

Brosh-Nissimov, Tal ;

Eshet, Yael ;

Ben-Simon, Shira ;

Ziv, Oren ;

Khan, Md Abdul Wadud ;

Amit, Moran ;

Ajami, Nadim J. ;

Barshack, Iris ;

Schachter, Jacob ;

Wargo, Jennifer A. ;

Koren, Omry ;

Markel, Gal ;

Boursi, Ben .

SCIENCE, 2021, 371 (6529) :602-+

[5]

Bender MJ, 2023, CELL, V186, P1846, DOI 10.1016/j.cell.2023.03.011

[6] Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study [J].

Berdeja, Jesus G. ;

Madduri, Deepu ;

Usmani, Saad Z. ;

Jakubowiak, Andrzej ;

Agha, Mounzer ;

Cohen, Adam D. ;

Stewart, A. Keith ;

Hari, Parameswaran ;

Htut, Myo ;

Lesokhin, Alexander ;

Deol, Abhinav ;

Munshi, Nikhil C. ;

O'Donnell, Elizabeth ;

Avigan, David ;

Singh, Indrajeet ;

Zudaire, Enrique ;

Yeh, Tzu-Min ;

Allred, Alicia J. ;

Olyslager, Yunsi ;

Banerjee, Arnob ;

Jackson, Carolyn C. ;

Goldberg, Jenna D. ;

Schecter, Jordan M. ;

Deraedt, William ;

Zhuang, Sen Hong ;

Infante, Jeffrey ;

Geng, Dong ;

Wu, Xiaoling ;

Carrasco-Alfonso, Marlene J. ;

Akram, Muhammad ;

Hossain, Farah ;

Rizvi, Syed ;

Fan, Frank ;

Lin, Yi ;

Martin, Thomas ;

Jagannath, Sundar .

LANCET, 2021, 398 (10297) :314-324

[7]

Burgos da Silva Marina, 2022, Blood, V140, P2385, DOI 10.1182/blood.2021015352

[8]

Cani PD, 2022, NAT REV GASTRO HEPAT, V19, P625, DOI 10.1038/s41575-022-00631-9

[9] Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab [J].

Chaput, N. ;

Lepage, P. ;

Coutzac, C. ;

Soularue, E. ;

Le Roux, K. ;

Monot, C. ;

Boselli, L. ;

Routier, E. ;

Cassard, L. ;

Collins, M. ;

Vaysse, T. ;

Marthey, L. ;

Eggermont, A. ;

Asvatourian, V. ;

Lanoy, E. ;

Mateus, C. ;

Robert, C. ;

Carbonnel, F. .

ANNALS OF ONCOLOGY, 2017, 28 (06) :1368-1379

[10] Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy [J].

Chong, Elise A. ;

Ruella, Marco ;

Schuster, Stephen J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07) :673-674

← 1 2 3 4 5 6 7 8 →